EUVIMEDEUVIMED entdecken
Crossref

Upcoming Medicare Part D changes for 2026

Vonda McClendon

NCODA Oncology and Hematology Meeting Abstracts · 15.06.2026

DOI: 10.67209/rtha7916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 15.06.2026. Verfasst von Vonda McClendon. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medicare Part D is a government program, which was enacted in 2006. This program helps Medicare beneficiaries pay for prescription drugs. It’s an optional, voluntary benefit offered through private insurance companies approved by the federal government. However, penalties may be incurred if patients do not have credible coverage. Part D helps cover the cost of prescription medications, including both brand-name and generic drugs, that are not typically covered by Medicare Part A or Part B.

Zitieren

APA

McClendon, V. (2026). Upcoming Medicare Part D changes for 2026. NCODA Oncology and Hematology Meeting Abstracts. https://doi.org/10.67209/rtha7916

Vancouver

McClendon V. Upcoming Medicare Part D changes for 2026. NCODA Oncology and Hematology Meeting Abstracts. 2026. doi:10.67209/rtha7916

BibTeX
@article{McClendon2026,
  author = {McClendon, Vonda},
  title = {Upcoming Medicare Part D changes for 2026},
  journal = {NCODA Oncology and Hematology Meeting Abstracts},
  year = {2026},
  doi = {10.67209/rtha7916}
}
Kostenlos starten →